Abstract
Get full access to this article
View all access options for this article.
References
1.
Brodie
BB
Axelrod
J.
Reichenthal
J.
Metabolism of theophylline (1,3-dimethyl-xanthine) in man . J Biol Chem
1952 ; 194 : 215 –22 .
2.
Cornish
HH
Christman
AA
. A study of the metabolism of theobromine, theophylline, and caffeine in man . J Biol Chem
1957 ; 228 : 315 –23 .
3.
Jenne
JW
Nagasawa
HT
Thompson
RD
. Relationship of urinary metabolites of theophylline to serum theophylline levels . Clin Pharmacol Ther
1976 ; 19 : 375 –81 .
4.
Ogilvie
RI
. Clinical pharmacokinetics of theophylline . Clin Pharmacokinet
1978 ; 3 : 267 –93 .
5.
Gutman
AB
. Uricosuric drugs with special references to probenecid and sulfinpyrazone . Adv Pharmacol
1966 ; 4 : 91 –142 .
6.
Hansten
PD
. Drug interactions , 4th ed.
Philadelphia : Lea and Febiger , 1979 : 511 –52 .
7.
Mitenko
PA
Ogilvie
RI
. Pharmacokinetics of intravenous theophylline . Clin Pharmacol Ther
1973 ; 14 : 509 –13 .
8.
Chen
Twd
Patton
TF
. Effect of probenecid on the pharmacokinetics of aminophylline . Drug Intell Clin Pharm
1983 ; 17 : 465 –6 .
9.
May
DC
Jarobe
CH
. Inhibition of clearance of dyphylline by probenecid (letter) . New Engl J Med
1981 ; 304 : 791 .
10.
Simons
KJ
Simons
FER
. Urinary excretion of dyphylline in humans . J Pharm Sci
1979 ; 68 : 1327 –9 .
11.
Hendles
L.
Weinberg
M.
Theophylline a “state of the art” review . Pharmacotherapy
1983 ; 3 : 2 –44 .